Recurrent Miscarriage Clinical Trial
Official title:
Investigation of Embryoscopy in Recurrent Pregnancy Loss
The purpose is to test the value of embryoscopy in women with missed abortions after
recurrent miscarriages (at least two previous miscarriages) in the past. This project will
assess two functions of embryoscopy:-
1. Whether embryoscopy allows the diagnosis of structural anomalies (disorganized
embryos). This is a fetal cause of embryo loss which cannot be diagnosed by other
means.
2. Whether embryoscopy allows an accurate biopsy of embryonic tissue for karyotyping.
However, it may be that embryoscopy will be found to have no advantage.
In this project, embryoscopy will be evaluated in women with missed abortions (pregnancies
which have ceased developing and in which the embryo is dead), after at least two previous
(recurrent) miscarriages. The procedure will have two main purposes:- To allow the diagnosis
of structural anomalies (disorganized embryos), and to allow an accurate biopsy of embryonic
tissue for karyotyping. Hence, this procedure will lead to a more accurate diagnosis of the
cause of recurrent miscarriage.
After confirmation of missed abortion by ultrasound, dilatation and curettage (D&C) is
normally performed under general anesthetic to evacuate the uterus in missed abortions. In
this project embryoscopy will be added to the standard D&C. An 8mm hysteroscope with
irrigation channel and 300 view will be used with continuous saline flow. The embryo will be
visualized, and the findings recorded. Biopsies will be taken for chromosomal analysis from
the embryo and the placental villi. Embryoscopy will be performed with a hysteroscope which
is in normal clinical use for investigating the uterine cavity, but for a slightly different
indication.
The first stage will be a pilot study on 20 patients to judge the value of embryoscopy.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01419392 -
Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages
|
Phase 4 | |
Completed |
NCT00193674 -
Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage
|
Phase 3 | |
Completed |
NCT06001060 -
Distinct Alterations in Gut Microbiota Composition Among Women of Reproductive Age With Elevated Homocysteine Levels.
|
||
Recruiting |
NCT05034250 -
Iron Status in Female Infertility and Recurrent Miscarriage
|
||
Completed |
NCT02681627 -
Sim (Scratch in Miscarriage) Study
|
N/A | |
Recruiting |
NCT02303171 -
Use of Warfarin After the First Trimester in Pregnant Women With APS
|
Phase 4 | |
Completed |
NCT02305420 -
EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage
|
Phase 4 | |
Recruiting |
NCT05824897 -
The Cohort Study of the Correlation Between Serum 25(OH)D Level and Pregnancy Outcome
|
||
Completed |
NCT03023137 -
Walking and Dietary Modification for Recurrent Early Miscarriages
|
N/A | |
Not yet recruiting |
NCT03132779 -
Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortion
|
Phase 1 | |
Completed |
NCT02184741 -
A Study of the Efficacy and Safety of GB-0998 in Patients With Unexplained Recurrent Miscarriage
|
Phase 3 | |
Active, not recruiting |
NCT02156063 -
A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)
|
Phase 2 | |
Recruiting |
NCT03902912 -
Effect of Prednisolone Treatment on Uterine Natural Killer Cells
|
Phase 3 | |
Not yet recruiting |
NCT03209063 -
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage
|
||
Completed |
NCT03970954 -
Low-dose Interleukin-2 in Women With Unexplained Miscarriages
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06249230 -
The Analysis of Risk Factors for Recurrent Pregnancy Loss and Prediction of Pregnancy Loss Risk
|
||
Recruiting |
NCT05725512 -
Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages
|
Phase 4 | |
Recruiting |
NCT05267678 -
Nutritional Deficiency and Recurrent Miscarriage
|
||
Completed |
NCT02694367 -
Expression of EPK in Recurrent Miscarriage
|
N/A | |
Completed |
NCT02504281 -
Study on the Association Between SXCI and RM and the Possible Genetic Mechanism
|